These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6331672)

  • 1. [Pharmacokinetics of cefotaxime after i.v. and i.p. administration in patients treated with continual ambulatory peritoneal dialysis (CAPD)].
    Matousovic K; Morávek J; Vítko S; Prát V; Horcicková M; Novák Z; Kuklík R; Krebs V; Janků J
    Cas Lek Cesk; 1984 Jun; 123(22):678-80. PubMed ID: 6331672
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.
    Johnson CA; Zimmerman SW; Bayer W; Craig WA
    Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
    Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in calculations of dialysis adequacy in patients using nightly intermittent peritoneal dialysis compared to CAPD.
    Friedlander MA; Rahman M; Tessman MJ; Hanslik TM; Ferrara KA; Newman LN
    Adv Perit Dial; 1995; 11():93-6. PubMed ID: 8534747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis.
    Tang SC; Lam B; Ku PP; Leung WS; Chu CM; Ho YW; Ip MS; Lai KN
    J Am Soc Nephrol; 2006 Sep; 17(9):2607-16. PubMed ID: 16885414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
    Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of intraperitoneal dialyzate on blood pressure during continuous ambulatory peritoneal dialysis.
    Fleming SJ; Powell J; Baker LR; Cattell WR; Greenwood R
    Clin Nephrol; 1983 Mar; 19(3):132-3. PubMed ID: 6839562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of cefotaxime and desacetyl cefotaxime during continuous ambulatory peritoneal dialysis.
    Heim KL; Halstenson CE; Comty CM; Affrime MB; Matzke GR
    Antimicrob Agents Chemother; 1986 Jul; 30(1):15-9. PubMed ID: 3752976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing dialysis prescriptions.
    Manuel A; Gray B; Coulis N; Brunier G; Desson F; Paton MA; Tobe S
    Adv Perit Dial; 1996; 12():136-42. PubMed ID: 8865888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved lymphocyte transformation in vitro of patients on continuous ambulatory peritoneal dialysis.
    Langhoff E; Ladefoged J
    Proc Eur Dial Transplant Assoc; 1983; 20():230-5. PubMed ID: 6657659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary function in uremic patients treated with continuous ambulatory peritoneal dialysis (CAPD)].
    Gómez Fernández P; Miguel Alonso JL; Sánchez Agudo L; Calatrava JM; Conesa J; Sánchez Sicilia L
    Med Clin (Barc); 1982 Sep; 79(5):219-23. PubMed ID: 7144303
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical problems in continuous ambulatory peritoneal dialysis (CAPD).
    Mallonga ET; van Coevorden F; Boeschoten EW; Southwood J; Krediet RT
    Neth J Surg; 1982 Jul; 34(3):117-22. PubMed ID: 7121871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotaxime and metabolite disposition in two pediatric continuous ambulatory peritoneal dialysis patients.
    Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JA
    Ann Pharmacother; 1992 Mar; 26(3):341-3. PubMed ID: 1554953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.